Fluid mechanical and physicochemical modeling interprets hypertension to be capable of inducing secondary complications

Medical Hypotheses

Volumn 68, Issue 5, 2007, Pages 967-978

  Huang, Chien Ning ^a,b   Peng, Chiung Huei ^a,b   Shih, Chün Ming ^b,c   Chiu, Wen Ta ^b,c   Chayu, Charng Cherng ^a,b   Chen, Kuan Chou ^b,c   Peng, Chiung Chi ^b,d   Peng, Robert Y ^a,b,c  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Cardinal Tien Junior College of Healthcare and Management   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; NITRIC OXIDE; PROSTAGLANDIN E2; THROMBOXANE;

AORTA COARCTATION; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DISSOCIATION; FLUID FLOW; GROWTH RETARDATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPOTHYROIDISM; INFERTILITY; KIDNEY ARTERY STENOSIS; LIGAND BINDING; MATHEMATICAL MODEL; OBESITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECEPTOR BINDING; SHEAR STRESS; VASCULAR DISEASE; VASCULAR RESISTANCE; VISCOSITY;

BLOOD VISCOSITY; CHEMISTRY, PHYSICAL; HUMANS; HYPERTENSION; LIGANDS; MODELS, THEORETICAL; RHEOLOGY; STRESS, MECHANICAL;

EID: 33847031281     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.10.017     Document Type: Article

References (42)

1. Philipp T., and Schaefers R. Metabolic syndrome and arterial hypertension. In: Hanefeld M., and Leonhardt W. (Eds). Das metabolische Syndrom; the metabolic syndrome (1997), GUSTAV FISHER, Jena, Stuttgart, Lubeck, Ulm 70-75
2. Robbins S.L., Cotran R.S., and Kumar V. Pathologic basis of disease. third ed. (1984), W.B. Saunders Company, Igaku-Shoin/Saunders pp. 1041-50
3. Assmaan G., Schulte H., and Cullen P. Metabolic syndrome and dyslipoproteinemia. In: Hanefeld M., and Leonhardt W. (Eds). The metabolic syndrome (1997), Gustav Fischer Verlag Jena 38-48
4. Heagerty A.M., Aalkjaer C., Bund S.J., Korsgaard N., and Mulvany M.J. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 21 4 (1993) 391-397
5. Mulvany M.J. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 17 (2002) 105-109
6. Hussein G., Goto H., Oda S., Sankawa U., Matsumoto K., and Watanabe H. Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biol Pharm Bull 29 4 (2006) 684-688
7. Kaul U.A., Singh B., Tyagi S., Bhargava M., Arora R., and Khalilullah M. Long-term results after balloon pulmonary valvuloplasty in adults. Am Heart J 126 5 (1993) 1152-1155
8. Hill M.F., and Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148 1 (1996) 291-300
9. Russo R., Vecchione C., Cosentino F., Natale A., Mele A.F., Muscolo M., Savoia C., Ganten D., Rubattu S., and Volpe M. Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats. J Hypertens 16 2 (1998) 151-156
10. Schini V.B., and Vanhoutte P.M. Role of the l-arginine-nitric oxide pathway in vascular smooth muscle. Eur Heart J 14 Suppl. I (1993) 16-21
11. Koga T., Takata Y., Kobayashi K., Takishita S., Yamashita Y., and Fujishima M. Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat. Hypertension 14 5 (1989) 542-548
12. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22 Suppl. 4 (1993) S1-S14
13. Luscher T.F., and Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol 24 Suppl. 3 (1994) S16-S26
14. Nakanishi N., Li W., Fukuda H., Takatorige T., Suzuki K., and Tatara K. Multiple risk factor clustering and risk of hypertension in Japanese male office workers. Ind Health 41 4 (2003) 327-331
15. Novak S., Stapleton L.M., Litaker J.R., and Lawson K.A. A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor. Diabetes Obes Metab 5 6 (2003) 388-396
16. Ritz E., and Bühler F.R. Insulin-Nebensache oder gar Ursache der Hypertonie?. Dtsch med Wschr 116 (1991) 1930-1932
17. Hirose H., Saito I., Kawabe H., and Saruta T. Insulin resistance and hypertension: seven-year follow-up study in middle-aged Japanese men (the KEIO study). Hypertens Res 26 10 (2003) 795-800
18. Haffner S.M. Insulin and blood pressure: fact or fantasy?. J Clin Endocrinol Metab 76 3 (1993) 541-543
19. Gurwitz J.H., Bohn R.L., Glynn R.J., Monane M., Mogun H., and Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med 118 4 (1993) 273-278
20. Mykkanen L., Kuusisto J., Pyorala K., and Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36 6 (1993) 553-559
21. Denker P.S., and Pollock V.E. Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch Intern Med 152 8 (1992) 1649-1651
22. Asch S., Wingard D.L., and Barrett-Connor E.L. Are insulin and hypertension independently related?. Ann Epidemiol 1 3 (1991) 231-244
23. Hanefeld M. Typ-II-Diabetes und Hypertonie als Komponenten des metabolischen Syndroms: Konsequenzen für die Therapie. Diab Stoffw 2 (1993) 396-402
24. Janka H.U., Balletshofer B., Becker A., Gick M.R., Hartmann J., Jung D., et al. Das metabolische Syndrom als potenter kardiovaskulärer Riskofaktor für vorzeitigen Tod bei Typ-II-Diabetikern. Diab Stoffw 1 (1992) 2-7
25. Dong J., Fujii S., Goto D., Furumoto T., Kaneko T., Zaman T.A., et al. Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives. Hypertens Res 26 9 (2003) 723-729
26. Guyton A.C. Human physiology and mechanisms of disease (1992), W.B. Saunders Company, Philadelphia, Pennsylvania, USA
27. Harper H.A., Rodwell V.W., and Mayes PA. Review of physiological chemistry. 16th ed. (1977), Lange Medical Publications, Los Altos, California 94022, USA pp. 584-5
28. Bailey JE, Ollis DF. Non-Newtonian fluids. In: Biochemical engineering fundamentals. 2nd ed. MacGraw-Hill International Editions/Chemical Engineering Series; 1986. p. 501-2.
29. Hsie J.T. Fluid transportation principles. Chemical engineering facilities 1 (2001), Chuan-Hua Scien Tech Book Co. 23-57
30. Wolfe SL. Molecular and cellular biology. Wadsworth Publishing Company, Belmont, California, A Division of Wadsworth Inc.; 1993. p. 236-69.
31. Scherge M., and Gorb S.N. Biological micro- and nano-tribology - nature's solutions. Nanoscience and technology series (2001), Springer-Verlag, Berlin Heidelberg p. 20-39
32. Laidler K.J., and Meiser J.H. The chemical bond. Physical chemistry (1984), Benjamin/Cummings Publishing Company Inc. 513-514
33. Raffa R.B. Ligand binding theory. Drug-receptor thermodynamics: introduction and applications. 1st ed. (2001), John Wiley and Sons Ltd., USA 72-76
34. Becker R.C. The role of blood viscosity in the development and progression of coronary artery disease. Cleve Clin J Med 60 5 (1993) 353-358
35. Koenig W., Hombach V., Ernst E., Sund M., Mraz W., and Keil U. Plasma viscosity as a cardiovascular risk factor. Circulation 86 3 (1992) 1045
36. Yarnell J.W., Baker I.A., Sweetnam P.M., Bainton D., O'Brien J.R., Whitehead P.J., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83 3 (1991) 836-844
37. Lowe G.D., Drummond M.M., Lorimer A.R., Hutton I., Forbes C.D., Prentice C.R., et al. Relation between extent of coronary artery disease and blood viscosity. Br Med J 280 6215 (1980) 673-674
38. Junker R., Heinrich J., Ulbrich H., Schulte H., Schonfeld R., Kohler E., et al. Relationship between plasma viscosity and the severity of coronary heart disease. Arterioscler Thromb Vasc Biol 18 6 (1998) 870-875
39. Fuchs J., Pinhas A., Davidson E., Rotenberg Z., Agmon J., and Weinberger I. Plasma viscosity, fibrinogen and haematocrit in the course of unstable angina. Eur Heart J 11 11 (1990) 1029-1032
40. Neumann F.J., Katus H.A., Hoberg E., Roebruck P., Braun M., Haupt H.M., et al. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J 66 6 (1991) 425-430
41. Lin C.C. Polymer fabrication engineering. first ed. (1983), Wen-Chin Book Co., Taipei, Taiwan [Chinese]
42. Romundstad S., Holmen J., Hallan H., Kvenild K., and Ellekjaer H. Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trondelag Health Study (HUNT), Norway. Circulation 108 22 (2003) 2783-2789